N/A
Completed N=63
Perioperative Use of Gabapentin To Decrease Narcotic Requirements in Spinal Fusion
Source: ClinicalTrials.gov NCT00726999 ↗Enrolled (actual)
63
Serious AEs
0.0%
Results posted
Dec 2010
Primary outcomePrimary: Amount of Morphine Consumed (mg/kg/hr) — 0.064; 0.044 mg/kg/h
Summary
Blinded study using oral gabapentin in load pre-operative (15mg/kg) and maintenance 5mg/kg three times a day (TID) for 5 days or discharge, Patient Controlled Analgesia (PCA) morphine and placebo group with similar pills, also PCA morphine. The goal is to measure morphine usage and incidence of morphine side effects (pruritis, days foley, days to first stool, sedation, pain scores, PCA use).
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Amount of Morphine Consumed (mg/kg/hr) |
0.047; 0.036 | — |
| SECONDARY Number of Ondansetron Doses Administered for Nausea |
2.0; 2.0 | — |
Eligibility Criteria
Inclusion Criteria
- ASA 1-2, Idiopathic Scoliosis
Exclusion Criteria
- ASA 3 or greater
- Neuromuscular scoliosis
- On narcotics baseline
Data sourced from ClinicalTrials.gov (NCT00726999). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.